- |||||||||| Trial completion: Ovarian Cancer and Immune Response to Flu Vaccine (clinicaltrials.gov) - Oct 5, 2016
P=N/A, N=37, Completed, Recruiting --> Active, not recruiting | N=35 --> 3 | Trial primary completion date: Nov 2017 --> Nov 2018 Recruiting --> Completed
- |||||||||| Trial completion, Trial primary completion date: Licensing Flu Shot Study (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=6098, Completed, Trial primary completion date: Apr 2016 --> Jan 2019 Not yet recruiting --> Completed | Trial primary completion date: Jan 2012 --> Oct 2011
- |||||||||| Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Trial primary completion date: Flu Vaccine Against Childhood Pneumonia, Bangladesh (clinicaltrials.gov) - Aug 31, 2016 P3, N=3508, Recruiting, Suspended --> Completed Trial primary completion date: Oct 2015 --> Apr 2017
- |||||||||| Trial completion, Trial initiation date, Trial primary completion date: The Effect of Time-Slot Scheduling on Flu Vaccination Rates (clinicaltrials.gov) - Aug 17, 2016
P=N/A, N=50000, Completed, Active, not recruiting --> Completed Not yet recruiting --> Completed | Initiation date: Sep 2010 --> Sep 2009 | Trial primary completion date: Nov 2010 --> Jul 2012
- |||||||||| Flucelvax (influenza virus trivalent vaccine) / CSL Behring
Enrollment change, Trial withdrawal: Flucelvax Pregnancy Registry (clinicaltrials.gov) - Aug 12, 2016 P=N/A, N=0, Withdrawn, Active, not recruiting --> Completed N=600 --> 0 | Recruiting --> Withdrawn
- |||||||||| Ampligen (rintatolimod) / AIM ImmunoTech
Trial primary completion date: Safety Study of FluMist With and Without Ampligen (clinicaltrials.gov) - Aug 9, 2016 P1/2, N=72, Active, not recruiting, N=600 --> 0 | Recruiting --> Withdrawn Trial primary completion date: Jun 2016 --> Jun 2017
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: Testing the AVI-7100 Flu Drug in Healthy Volunteers (clinicaltrials.gov) - Jul 1, 2016
P1, N=66, Completed, Trial primary completion date: Dec 2016 --> Jun 2017 Active, not recruiting --> Completed | N=50 --> 66 | Trial primary completion date: Nov 2016 --> Jun 2016
- |||||||||| Remicade (infliximab) / J&J
Trial completion, Enrollment change: Infliximab IBD Influenza Vaccine Study (clinicaltrials.gov) - May 9, 2016 P=N/A, N=137, Completed, Active, not recruiting --> Recruiting Not yet recruiting --> Completed | N=180 --> 137
- |||||||||| Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment closed, Enrollment change, Trial primary completion date, Adverse events: IVVE:Pilot: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (clinicaltrials.gov) - May 5, 2016 P4, N=600, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | N=3500 --> 600 | Trial primary completion date: Dec 2019 --> Dec 2016
|